Lorenzo
@cosimo1464at the end of the day you’re investing in people
Similar User
@MikeEdmunds1981
@Riz_YNWA
@aimisthegame121
@bent_copers
@shncoe
@MattBrian1988
@11invest
@RasabWaheed
@Aim_Eudaimonia
@Conormunro123
@garciastone
@silverstonadict
@BruceLoosegoose
@grahamrtomo
@trader24095618
My expectation is that the potential value here is too great for #AVCT to relinquish to a LD or TO, so my feeling is that this moves more along the lines of a JV
Genedrive’s CSO Gino Miele spoke to Elena Boland at TTP plc about the potential for CYP2C19 genotyping in acute care. Read the full story: ttp.com/insights/distr…
The dilution involved in a Nasdaq listing are multiples of AS’s last hurrah! Just don’t go there is my advice. And I’m with CC to remain independent and not sell the farm and draw the divi far into the golden future.
The dilution involved in a Nasdaq listing are multiples of AS’s last hurrah! Just don’t go there is my advice. And I’m with CC to remain independent and not sell the farm and draw the divi far into the golden future.
Another welcome trial ~ these insurers no doubt see the potential and the more trials the more it reduces the odds of a hit! Good news - hope it moves the dial on the sp…but fear we need income to do that!
Ondo InsurTech PLC - Ageas UK to trial LeakBot #LSE #ONDO @OndoPlc #claimsprevention #Leakbot Read the RNS here: voxmarkets.co.uk/rns/announceme… #voxmarkets #investing #shares #RNS via @voxmarkets
…not a regular occurrence!’
#AVCT - I think it interesting that the Co will provide ‘a business update after the AGM’ - this is a regular occurrence. I’m beginning to get the feeling that the company have a chart for getting out of the doldrums!
Note, Novartis has an ‘exclusive worldwide rights to develop and commercialize therapeutic applications for a library of Fibroblast Activation Protein (FAP) targeting agents including FAPI-46 and FAPI-74’. #AVCT
#AVCT - could there be a practice whereby a ‘short’ is taken - thus ‘depressing’ the price and permitting another party to ‘load up’ at a cheaper market price?
Why precision-guided chemotherapy has driven a dealmaking boom ft.com/content/85ab8f… via @ft #avct - this is a great commentary on new but limited oncology … they still haven’t got their heads around Avacta’s great contribution to this space. I suppose it will out in the end!
Last I will say on this but if we ALL #AVCT holders put a high sell-order on our stocks, I’m pretty sure this cannot be circumvented by inter-broker securities lending. For me as a Halifax SD customer, the cost is £2. PI’s should no longer be cannon fodder for II’s, HF’s etc.
#ondo #leakbot and met with sustained buying of the shares throughout the morning. Congratulations to @foster_ideas and the team
In case you missed it, more commentary on the successful deployment of LeakBot in Ohio with Fortune 100 insurer Nationwide #ONDO
#avct - I don’t have a lot of time on my hands generally - I have to work to enable to keep buying Avacta stock - but so incensed am I by the short taken by GSA Capital that I have written to them and asked them to cease with their parasitic practice. May I encourage others.
Oh get over yourself… ‘so so rude for blocking you’ what do you expect when your accusation is likely sans evidence of any description. There are many who do deep research into this stock and it’s all gratefully received by some of us who have a ‘day job’.
It's not like I don't try to help. I pointed out that @MylesMcNulty was pumping #AVCT, #BEN, #EISB, #TGR and was most likely being paid to do so. He just blocked me. So so rude! All these stocks are down heavily or have gone bust since.
However this maybe an object lesson in the difference between how CO’s fare on different market platforms in us and uk
$bcyc and #avct seemingly close competitors. It is a big market, however.
Bicycle Therapeutics Set to Redefine Cancer Treatment Landscape with Trailblazing Therapies at 2024 AACR Annual Meeting: $BCYC Bicycle Therapeutics to Showcase Groundbreaking Therapies at 2024… dlvr.it/T3g9n6 #NASDAQ #customers #BCYC #MajorPharmaceuticalPreparations
#avct and @coughlin582 give insights into ADC vs PDC’s - the new Ford vs Ferrari where Ferrari powers ahead over time!
Our April newsletter is now live: consiliumsc.activehosted.com/index.php?acti… Featuring insights from Christina Coughlin, MD, PhD, Head of R&D at @avacta on the @AACR Annual Meeting and Dr Danuta Jeziorska, CEO and Co-Founder of Nucleome Therapeutics on World DNA Day. #ICRConsilium #Newsletter
United States Trends
- 1. Hunter 259 B posts
- 2. Justin Tucker 27,5 B posts
- 3. Ravens 67,8 B posts
- 4. Joe Biden 157 B posts
- 5. Eagles 95,4 B posts
- 6. Lamar 64,2 B posts
- 7. Bryce Young 14,7 B posts
- 8. Panthers 25 B posts
- 9. #UniswapHack 88,6 B posts
- 10. Bucs 11,5 B posts
- 11. Saquon 24,9 B posts
- 12. #KeepPounding 2.867 posts
- 13. Donovan Mitchell 2.243 posts
- 14. Cooper DeJean 8.326 posts
- 15. Adam Thielen 4.218 posts
- 16. Chuba 3.208 posts
- 17. Jalen Carter 6.727 posts
- 18. Baker 43,2 B posts
- 19. #pardon N/A
- 20. Bucky Irving 3.300 posts
Who to follow
-
MNE
@MikeEdmunds1981 -
#keepitreal
@Riz_YNWA -
aimisthegame12345
@aimisthegame121 -
Brent Coppers
@bent_copers -
Shaun
@shncoe -
Matt
@MattBrian1988 -
11invest
@11invest -
Waheed Rasab
@RasabWaheed -
Eudaimonia Capital
@Aim_Eudaimonia -
Conor munro
@Conormunro123 -
3bes
@garciastone -
silverstoneaddict
@silverstonadict -
Loosegoose
@BruceLoosegoose -
GT
@grahamrtomo -
MTrader
@trader24095618
Something went wrong.
Something went wrong.